Project Grant R01DA066648
- The National Institute on Drug Abuse awarded New York University a cooperative agreement valued at $1,240,576 on March 15, 2026, to develop and validate an integrated system for life-long, high-resolution monitoring of mouse colony life to study neurobehavioral mechanisms of social behavior and familial structure. This award falls under the Drug Use and Addiction Research Programs (CFDA 93.279), which supports basic, clinical, translational, and implementation research to advance knowledge and...
- The National Institute on Drug Abuse awarded President and Fellows of Harvard College $120,937 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on the control of behavioral and neural variability during perceptual decision-making under uncertainty. The research combines computational modeling with human behavioral experimentation and neuroimaging to investigate whether individuals can increase the accuracy of perceptual decisions by...
- The National Institute on Drug Abuse awarded The Trustees of Princeton University $473,543 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop theoretical frameworks and computational methods for identifying mechanisms of cognitive computations from neural recordings and behavioral data. The award funds three research aims: formulating mathematical theory relating the dimensionality of neural population dynamics to single-cell selectivity patterns...
- The National Institute on Drug Abuse awarded New York University $103,607 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct dissertation research on polysubstance use patterns and their associations with methadone maintenance treatment receipt and discontinuation among people who use drugs in New York State. The research uses a mixed-methods approach guided by the Social Ecological Model to identify latent polysubstance use patterns through urine...
- The National Institute on Drug Abuse awarded Northwestern University $722,218 on March 1, 2026, for research on the effects of developmental environment on dopamine circuit structure and function under the Drug Use and Addiction Research Programs (CFDA 93.279). The project runs through December 31, 2030, with place of performance in Chicago, Illinois. The research investigates how early life stress produces long-lasting impacts on dopamine circuit function and development into adulthood, using...
- The National Institute on Drug Abuse awarded The University of Chicago $390,600 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop coarse-graining theory, models, and methods that translate approaches to describing emergent collective behavior in neural systems into usable code for the broad neuroscience community. The project will produce data analysis code made available to neuroscience researchers for use on their own datasets. Three theorists...
- The National Institute on Drug Abuse awarded New York University a $854,818 cooperative agreement on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct computational analyses of family auditory communication linking behavior, vocalization, and neural dynamics in Mongolian gerbils. The project integrates audio, video, and neural data to uncover the behavioral meaning of distinctive vocal bouts and test how cortical mechanisms support social decision-making...
- The National Institute on Drug Abuse awarded the Lieber Institute Inc. $1.855 million on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop three-dimensional cellular resolution spatio-molecular maps of the human nucleus accumbens across its anterior-posterior axis. The nucleus accumbens is a key node in the brain's reward circuitry, and perturbations in reward signaling are implicated in substance use disorders. The project extends prior spatial...
- The National Institute on Drug Abuse awarded $493,444 to The Regents of the University of California, operating Lawrence Berkeley National Laboratory, on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The research examines feedback controllability of neural population dynamics, specifically how feedback control principles shape neural activity patterns underlying brain functions from perception to cognition and action. The project develops normative theories...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,080,885 to the University of Southern California (USC) from September 2024 to September 2027. The funding supports the development of novel neural network models that can capture the nonlinear dynamics of large-scale brain networks and their relationship to behavior. The models will have flexible inference capabilities, enabling real-time,...
The National Institute on Drug Abuse awarded New York University $411,187 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct basic research on trial-to-trial variability in neural circuits and its impact on neural computation and behavioral accuracy. The project integrates theoretical models, statistical methods, and experimental datasets to characterize noise in neural circuits using rodent navigation and nonhuman primate decision-making tasks. The research will develop new statistical methods for estimating noise statistics in realistic experimental conditions, new theories of noisy neural computation in multi-layer and recurrent neural network models, and deliver user-friendly open-source statistical software for noise correlation analysis and population-level neural representation error tracking. The statistical tools will be benchmarked using in silico deep network models and in vivo experimental datasets from collaborators. New York University is the recipient, with place of performance in New York, New York. The period of performance runs from September 1, 2026, through June 30, 2029. The assistance type is Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $411.2k | 8/28/26 |